Literature DB >> 2174078

Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study.

I E Ormerod1, H M Waddy, A G Kermode, N M Murray, P K Thomas.   

Abstract

In a consecutive series of 30 patients with chronic inflammatory demyelinating polyneuropathy (CIDP) minor clinical evidence of CNS involvement was found in five. Cranial magnetic resonance imaging (MRI) was performed in 28 and revealed abnormalities consistent with demyelination in nine patients aged less than 50 years and abnormalities in five aged 50 years or over. Measurements of central motor conduction time (CMCT) were obtained in 18 and showed unilateral or bilateral abnormalities in six. It is concluded that subclinical evidence of central nervous system (CNS) involvement is common, at least in patients with CIDP in the United Kingdom, but that clinically evident signs of CNS disease are infrequent. The association of a multiple sclerosis-like syndrome with CIDP is rare.

Entities:  

Mesh:

Year:  1990        PMID: 2174078      PMCID: PMC1014259          DOI: 10.1136/jnnp.53.9.789

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone.

Authors:  J H AUSTIN
Journal:  Brain       Date:  1958-06       Impact factor: 13.501

3.  'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy.

Authors:  W C Schoene; S Carpenter; P O Behan; N Geschwind
Journal:  Brain       Date:  1977-12       Impact factor: 13.501

4.  Recurrent and chronic relapsing Guillain-Barré polyneuritis.

Authors:  P K Thomas; R G Lascelles; J F Hallpike; R L Hewer
Journal:  Brain       Date:  1969       Impact factor: 13.501

5.  [The anatomo-clinical association of hypertrophic neuritis and multiple sclerosis].

Authors:  V Ninfo; N Rizzuto; H Terzian
Journal:  Acta Neurol (Napoli)       Date:  1967 Mar-Apr

Review 6.  Multiple sclerosis: epidemiology and HLA associations.

Authors:  W I McDonald
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

7.  [Histopathology of the lumbosacral spinal cord and the cauda equina in a series of proven cases of multiple sclerosis. Report of anatomo-clinical data and of urinary symptomatology].

Authors:  C J Ketelaer; A Leruitte; O Perier
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

8.  Hypertrophic neuropathy and multiple sclerosis.

Authors:  N L Rosenberg; D Bourdette
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

9.  Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis.

Authors:  H Lassmann; H Budka; G Schnaberth
Journal:  Arch Neurol       Date:  1981-02

10.  Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy.

Authors:  Y I Ro; C B Alexander; S J Oh
Journal:  Muscle Nerve       Date:  1983-05       Impact factor: 3.217

View more
  19 in total

1.  MRI lesions in younger healthy adults.

Authors:  A Ferbert; A Thron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 2.  Localization of the pathological process in Miller Fisher syndrome.

Authors:  F Barontini; S Di Lollo; S Maurri; P Lambruschini
Journal:  Ital J Neurol Sci       Date:  1992-04

3.  Sixth nerve palsy from a CNS lesion in chronic inflammatory demyelinating polyneuropathy.

Authors:  J H Wokke; L H van den Berg; J P van Schaik
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

4.  The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.

Authors:  K B Yeung; P K Thomas; R H King; H Waddy; R G Will; R A Hughes; N A Gregson; S Leibowitz
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

Review 5.  A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee.

Authors:  S Groppa; A Oliviero; A Eisen; A Quartarone; L G Cohen; V Mall; A Kaelin-Lang; T Mima; S Rossi; G W Thickbroom; P M Rossini; U Ziemann; J Valls-Solé; H R Siebner
Journal:  Clin Neurophysiol       Date:  2012-02-19       Impact factor: 3.708

Review 6.  Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Mohamed Mahdi-Rogers; Ruth Brassington; Angela A Gunn; Pieter A van Doorn; Richard Ac Hughes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

Review 7.  Electrophysiological sequels of inflammatory demyelination.

Authors:  W A Nix
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  Peripheral third cranial nerve enhancement in multiple sclerosis.

Authors:  M Tariq Bhatti; Ilona M Schmalfuss; Lorna S Williams; Ronald G Quisling
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

9.  Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study.

Authors:  J M Léger; A B Younes-Chennoufi; M Zuber; P Bouche; M O Jauberteau; D Dormont; F Danon; N Baumann; P Brunet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

10.  Combined central and peripheral acute demyelination.

Authors:  D Pareyson; C Ciano; F Fiacchino; M Gemma; M Savoiardo; A Sghirlanzoni
Journal:  Ital J Neurol Sci       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.